Painreform Stock Net Income
| PRFX Stock | USD 0.74 0.02 3.04% |
As of the 27th of January, Painreform holds the Coefficient Of Variation of (1,392), risk adjusted performance of (0.04), and Variance of 55.36. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.
Painreform's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Painreform's valuation are provided below:We have found one hundred twenty available trending fundamental ratios for Painreform, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Painreform recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 1.7 M in 2026. Enterprise Value is likely to rise to about (2.9 M) in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -7.9 M | -7.5 M | |
| Net Loss | -13.1 M | -12.5 M | |
| Net Loss | -13.1 M | -12.5 M | |
| Net Loss | (36.99) | (38.84) | |
| Net Income Per E B T | 1.15 | 1.31 |
Painreform | Net Income | Build AI portfolio with Painreform Stock |
Latest Painreform's Net Income Growth Pattern
Below is the plot of the Net Income of Painreform over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Painreform financial statement analysis. It represents the amount of money remaining after all of Painreform operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Painreform's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (14.59 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Painreform Net Income Regression Statistics
| Arithmetic Mean | (5,234,879) | |
| Coefficient Of Variation | (89.01) | |
| Mean Deviation | 4,019,137 | |
| Median | (2,090,000) | |
| Standard Deviation | 4,659,475 | |
| Sample Variance | 21.7T | |
| Range | 13.8M | |
| R-Value | (0.84) | |
| Mean Square Error | 6.7T | |
| R-Squared | 0.71 | |
| Significance | 0.000021 | |
| Slope | (778,251) | |
| Total Sum of Squares | 347.4T |
Painreform Net Income History
Other Fundumenentals of Painreform
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Painreform Net Income component correlations
Painreform Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Painreform is extremely important. It helps to project a fair market value of Painreform Stock properly, considering its historical fundamentals such as Net Income. Since Painreform's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Painreform's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Painreform's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Painreform. If investors know Painreform will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Painreform listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Painreform is measured differently than its book value, which is the value of Painreform that is recorded on the company's balance sheet. Investors also form their own opinion of Painreform's value that differs from its market value or its book value, called intrinsic value, which is Painreform's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Painreform's market value can be influenced by many factors that don't directly affect Painreform's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Painreform's value and its price as these two are different measures arrived at by different means. Investors typically determine if Painreform is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Painreform's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Painreform 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Painreform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Painreform.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Painreform on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Painreform or generate 0.0% return on investment in Painreform over 90 days. Painreform is related to or competes with Universe Pharmaceuticals, Elevai Labs, Dermata Therapeutics, Psyence Biomedical, Avenue Therapeutics, Virax Biolabs, and NewcelX. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More
Painreform Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Painreform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Painreform upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 53.02 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 9.38 |
Painreform Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Painreform's standard deviation. In reality, there are many statistical measures that can use Painreform historical prices to predict the future Painreform's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.74) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (0.20) |
Painreform January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 5.04 | |||
| Coefficient Of Variation | (1,392) | |||
| Standard Deviation | 7.44 | |||
| Variance | 55.36 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.74) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 53.02 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 9.38 | |||
| Skewness | 2.16 | |||
| Kurtosis | 10.1 |
Painreform Backtested Returns
Painreform maintains Sharpe Ratio (i.e., Efficiency) of -0.0736, which implies the firm had a -0.0736 % return per unit of risk over the last 3 months. Painreform exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Painreform's Coefficient Of Variation of (1,392), variance of 55.36, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide. The company holds a Beta of 2.77, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Painreform will likely underperform. At this point, Painreform has a negative expected return of -0.57%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and price action indicator , to decide if Painreform performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.49 |
Average predictability
Painreform has average predictability. Overlapping area represents the amount of predictability between Painreform time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Painreform price movement. The serial correlation of 0.49 indicates that about 49.0% of current Painreform price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Painreform reported net income of (14.59 Million). This is 104.27% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.55% higher than that of the company.
Painreform Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Painreform's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Painreform could also be used in its relative valuation, which is a method of valuing Painreform by comparing valuation metrics of similar companies.Painreform is currently under evaluation in net income category among its peers.
Painreform Current Valuation Drivers
We derive many important indicators used in calculating different scores of Painreform from analyzing Painreform's financial statements. These drivers represent accounts that assess Painreform's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Painreform's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 13.1M | 4.4M | 3.4M | 1.5M | 1.8M | 1.7M | |
| Enterprise Value | (3.5M) | 303.9K | (4.6M) | (2.7M) | (3.1M) | (2.9M) |
Painreform Institutional Holders
Institutional Holdings refers to the ownership stake in Painreform that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Painreform's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Painreform's value.| Shares | Justinvest Llc | 2025-06-30 | 13.7 K | Ubs Group Ag | 2025-06-30 | 6.1 K | Advisor Group Holdings, Inc. | 2025-06-30 | 193 | Sbi Securities Co Ltd | 2025-06-30 | 6.0 | Apollon Wealth Management, Llc | 2025-03-31 | 0.0 | Tower Research Capital Llc | 2025-06-30 | 0.0 | Barclays Plc | 2025-03-31 | 0.0 | Hrt Financial Llc | 2025-03-31 | 0.0 |
Painreform Fundamentals
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | (354.16 K) | ||||
| Shares Outstanding | 2.01 M | ||||
| Shares Owned By Insiders | 9.39 % | ||||
| Shares Owned By Institutions | 2.45 % | ||||
| Number Of Shares Shorted | 67 K | ||||
| Price To Book | 0.36 X | ||||
| EBITDA | (14.55 M) | ||||
| Net Income | (14.59 M) | ||||
| Cash And Equivalents | 13.85 M | ||||
| Cash Per Share | 1.30 X | ||||
| Total Debt | 45 K | ||||
| Current Ratio | 29.02 X | ||||
| Book Value Per Share | 4.19 X | ||||
| Cash Flow From Operations | (12.62 M) | ||||
| Short Ratio | 0.68 X | ||||
| Earnings Per Share | 29.90 X | ||||
| Target Price | 12.0 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 1.87 M | ||||
| Total Asset | 4.53 M | ||||
| Retained Earnings | (56.45 M) | ||||
| Working Capital | 1.99 M | ||||
| Net Asset | 4.53 M |
About Painreform Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Painreform's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Painreform using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Painreform based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.